Cardiovascular considerations in selection of anti-panic pharmacotherapy

J Psychiatr Res. 1990:24 Suppl 2:43-9. doi: 10.1016/0022-3956(90)90034-n.

Abstract

Patients with panic disorder may be at increased risk for cardiovascular morbidity and mortality. There is also preliminary evidence that some cardiovascular risk factors may be increased in patients with panic disorder. Since anti-panic medications can alter cardiovascular function, the cardiovascular effect of these medications should be considered, particularly when used in patients with cardiovascular disease. This article will review the cardiovascular side effects of anti-panic medications.

Publication types

  • Review

MeSH terms

  • Anti-Anxiety Agents / adverse effects*
  • Anti-Anxiety Agents / therapeutic use
  • Antidepressive Agents, Tricyclic / adverse effects
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Anxiety Disorders / drug therapy*
  • Arousal / drug effects*
  • Benzodiazepines
  • Electrocardiography / drug effects*
  • Hemodynamics / drug effects*
  • Humans
  • Monoamine Oxidase Inhibitors / adverse effects
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Panic / drug effects*
  • Risk Factors

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents, Tricyclic
  • Monoamine Oxidase Inhibitors
  • Benzodiazepines